Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. structure-based design efforts lead to new nucleoside PRMT5 inhibitors

Sep. 1, 2021

Biallelic THUMPD1 variants linked to syndromic intellectual developmental disorder

Sep. 1, 2021

Rockefeller University presents new LATS1 inhibitors

Sep. 1, 2021

Japanese researchers synthesize new PROTACs for cancer

Sep. 1, 2021

Arbutus Biopharma identifies PD-L1 antagonists

Sep. 1, 2021

Fileclo Sp zoo discloses new compounds for cancer

Sep. 1, 2021

Eternity Bioscience patents new ADAMTS inhibitors

Sep. 1, 2021

Loss of fbn2b tied to cardiovascular manifestations overlapping with Marfan syndrome

Sep. 1, 2021

Discovery of CPL-302415 as promising preclinical candidate for SLE

Sep. 1, 2021

Novel oxidative-phosphorylation inhibitors with promising antitumor activity in vivo

Sep. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...